๐
Isembyld
apitegromab
Muscular Atrophy, Spinal
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of muscular atrophy in patients aged 2 years and older, with 5q spinal muscular atrophy (SMA), who are non-ambulatory and currently receiving a survival motor neuron 2 (SMN2) targeted treatment
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/isembyld